Burcon NutraScience Corporation (BRCNF)

Burcon NutraScience Income Statement

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	1.48	0.38	0.18	0.36	0.17	0.26
Revenue Growth (YoY)	-	106.88%	-49.34%	112.23%	-33.70%	730.75%
Cost of Revenue	6.81	1.25	-	-	-	-
Gross Profit	-5.33	-0.87	0.18	0.36	0.17	0.26
Selling, General & Admin	3.03	3.78	3.62	3.76	4.28	3.65
Research & Development	1.63	3.05	3.58	4.13	3.29	0.41
Other Operating Expenses	-	-	-	-	-	0.79
Operating Income	-9.98	-7.7	-7.02	-7.53	-7.4	-4.6
Total Non-Operating Income (Expense)	-2.92	-0.57	-0.43	-17.84	-2.86	3.98
Pretax Income	-12.9	-8.26	-7.45	-25.36	-10.26	-0.62
Net Income	-12.9	-8.26	-7.45	-25.36	-10.26	-0.62
Net Income to Common	-12.9	-8.26	-7.45	-25.36	-10.26	-0.62
Shares Outstanding (Basic)	13	13	7	6	5	3
Shares Outstanding (Diluted)	13	13	7	6	5	3
Shares Change (YoY)	77.90%	78.59%	28.84%	1.56%	75.85%	-21.77%
EPS (Basic)	1.06	1.06	1.23	-4.60	-1.80	-0.20
EPS (Diluted)	1.06	1.06	1.23	-4.60	-1.80	-0.20
EPS Growth	-10.92%	-13.82%	-	-	-	-
Free Cash Flow	-8.12	-5.82	-5.9	-6.38	-5.97	-3.93
Free Cash Flow Per Share	-	-	-	-	-1.10	-
Gross Margin	-359.48%	-228.31%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-673.98%	-2018.75%	-3807.23%	-2067.88%	-4314.19%	-1776.74%
Profit Margin	-870.87%	-2166.98%	-4038.96%	-6969.87%	-5982.59%	-238.74%
FCF Margin	-548.04%	-1525.02%	-3202.50%	-1751.91%	-3478.73%	-1518.48%
EBITDA	-8.36	-6.86	-6.32	-6.86	-7.14	-4.47
EBITDA Margin	-564.08%	-1799.96%	-3427.12%	-1886.24%	-4161.73%	-1729.09%
EBIT	-9.98	-7.7	-7.02	-7.53	-7.4	-4.6
EBIT Margin	-673.98%	-2018.75%	-3807.23%	-2067.88%	-4314.19%	-1776.74%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.